BONESUPPORT CEO Emil Billbäck Shares Insights About Cerament G, the New Bone Void Filler Launching in the US
XTalks
JUNE 1, 2022
This product has quickly gotten to about $14 million USD in sales and an annual growth of more than 50 percent. What was special about this latest FDA approval from the company’s (BONESUPPORT’s) commercial perspective? Billbäck : BONESUPPORT already sells the “basic” CERAMENT without antibiotic elution.
Let's personalize your content